- The company delivered another good quarter and has again raised the full-year outlook while the shares have now pulled back a bit.
- The shares remain fully valued though, but that doesn’t mean they don’t offer opportunities.
- The company is likely to keep growing at 10%-15%, with expanding margins, operational leverage and increasing cash flow opening up the possibilities of a declining share count.
- There are interesting opportunities in their Opioid Safety Network and Hospital Automation, which might shift the company a little towards a more attractive business model.
Masimo: An Expensive Growth Stock That Keeps On Growing
October 17th, 2019 · No Comments